Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes

    Authors

    C. W. Younce; J. L. Niu; J. Ayala; M. A. Burmeister; L. H. Smith; P. Kolattukudy;J. E. Ayala

    Comments

    Authors: contact us about adding a copy of your work at [email protected]

    Abbreviated Journal Title

    J. Mol. Cell. Cardiol.

    Keywords

    Glucagon-like peptide-1; Exendin-4; Monocyte chemoattractant protein-1; Inflammation; Cardiomyopathy; ENDOPLASMIC-RETICULUM STRESS; SIGNALING PATHWAY; ACTIVATION; INHIBITION; BIOLOGY; SERCA2A; AGONIST; HEART; Cardiac & Cardiovascular Systems; Cell Biology

    Abstract

    The incretin hormone glucagon-like peptide-1 (Glp1) is cardioprotective in models of ischemia-reperfusion injury, myocardial infarction and gluco/lipotoxicity. Inflammation is a factor in these models, yet it is unknown whether Glp1 receptor (Glp1r) agonists are protective against cardiac inflammation. We tested the hypothesis that the Glp1r agonist Exendin-4 (Ex4) is cardioprotective in mice with cardiac-specific monocyte chemoattractant protein-1 overexpression. These MHC-MCP1 mice exhibit increased cardiac monocyte infiltration, endoplasmic reticulum (ER) stress, apoptosis, fibrosis and left ventricular dysfunction. Ex4 treatment for 8 weeks improved cardiac function and reduced monocyte infiltration, fibrosis and apoptosis in MHC-MCP1 mice. Ex4 enhanced expression of the ER chaperone glucose-regulated protein-78 (GRP78), decreased expression of the proapoptotic ER stress marker CCAAT/-enhancer-binding protein homologous protein (CHOP) and increased expression of the ER calcium regulator Sarco/Endoplasmic Reticulum Calcium ATPase-2a (SERCA2a). These findings suggest that the Glplr is a viable target for treating cardiomyopathies associated with stimulation of pro-inflammatory factors. CI (c) 2014 Elsevier Ltd. All rights reserved.

    Journal Title

    Journal of Molecular and Cellular Cardiology

    Volume

    76

    Publication Date

    1-1-2015

    Document Type

    Article

    Language

    English

    First Page

    172

    Last Page

    176

    WOS Identifier

    WOS:000344202800021

    ISSN

    0022-2828

    Share

    COinS
     

    Accessibility Statement

    This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.